Market Insights

Beacon Brainstorms Podcast:
Alessio Ciulli on Drug Design and the Future of TPD

Sofia Rodriguez talks to Alessio Ciulli, professor of chemical structural biology at the University of Dundee and Co-Founder of Amphista Therapeutics, the leading Europe-based TPD company. Join us to hear about his lab's ground-breaking research into protein degradation, the opening of the new Centre for Targeted Protein Degradation (CeTPD), and the opportunities and challenges of novel degrader design.